Thyroid Cancer

Lenvima approved for common thyroid cancer

(HealthDay)—Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer (DTC) that has progressed despite radioactive iodine therapy, the agency said Friday in ...

Feb 13, 2015
popularity 5 / 5 (1) | comments 0

MS patients cheer FDA OK of new drug

Patients facing limited options for treating their relapsing multiple sclerosis are celebrating the FDA's approval of a new aggressive drug treatment. The ruling reverses the agency's decision a year ago that the drug was ...

Dec 29, 2014
popularity 3.8 / 5 (8) | comments 0

Radiation exposure linked to aggressive thyroid cancers

For the first time, researchers have found that exposure to radioactive iodine is associated with more aggressive forms of thyroid cancer, according to a careful study of nearly 12,000 people in Belarus who were exposed when ...

Oct 28, 2014
popularity 5 / 5 (1) | comments 0

Thyroid cancer is a thyroid neoplasm that is malignant. It can be treated with radioactive iodine or surgical resection of the thyroid gland. Chemotherapy or radiotherapy may also be used.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News